Sharon Worcester, MA

News

Higher alcohol consumption linked to early-onset CRC

Author:: Sharon Worcester, MA

Publish date: July 7, 2023

Compared with light drinking, moderate and heavy drinking were associated with a significantly elevated risk of early-onset CRC.

News

FDA approves talazoparib for metastatic prostate cancer

Author:: Sharon Worcester, MA

Publish date: June 23, 2023

The new approval is based on findings from the randomized, placebo-controlled, phase 3 TALAPRO-2 trial.

News

Widespread carboplatin, cisplatin shortages: NCCN survey

Author:: Sharon Worcester, MA

Publish date: June 9, 2023

Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.

News

FDA approves new indication for avapritinib

Author:: Sharon Worcester, MA

Publish date: May 23, 2023

Purported “first and only approved medicine” to treat adults with indolent systemic mastocytosis has been greenlit by the FDA.

News

Focus of new ASH VTE guidelines: Thrombophilia testing

Author:: Sharon Worcester, MA

Publish date: May 23, 2023

New guidelines recommend testing for thrombophilia in patients with VTE provoked by a nonsurgical major transient risk factor or associated with CO...

News

SCC from breast implants: Negligible risk, study finds

Author:: Sharon Worcester, MA

Publish date: May 8, 2023

Regarding SCC, “whether the observed elevated risk is associated with the implants is difficult to interpret because it is based on only one case a...

News

Phase 3 trial: Maribavir yields post-transplant benefits

Author:: Sharon Worcester, MA

Publish date: May 5, 2023

Study findings “provide supportive evidence of the potential for long-term benefit” with maribavir for the treatment of post-transplant CMV.

News

Novel fluorescence guidance improves lumpectomy outcomes

Author:: Sharon Worcester, MA

Publish date: May 5, 2023

Pegulicianine (Lumisight), an investigational and activatable fluorescent imaging agent used with a novel direct visualization system, helped ident...

News

Motixafortide may improve MM outcomes

Author:: Sharon Worcester, MA

Publish date: April 26, 2023

A new drug approval for motixafortide is currently under review by the Food and Drug Administration.

News

FDA approves new Merkel cell carcinoma treatment

Author:: Sharon Worcester, MA

Publish date: March 23, 2023

This marks the first regulatory approval for retifanlimab-dlwr, a PD-1 inhibitor.

News

Depression tied to inflammation and survival in lung cancer

Author:: Sharon Worcester, MA

Publish date: March 21, 2023

A new study’s findings underscore the importance of assessing and treating depression in patients with cancer, particularly given the high rate of ...

News

Venetoclax shows promise for r/r hairy cell leukemia

Author:: Sharon Worcester, MA

Publish date: March 10, 2023

Italian study suggests benefits of administering venetoclax for patients with r/r cases of hairy cell leukemia, a rare blood cancer,

News

FDA strengthens mammography regulations: Final rule

Author:: Sharon Worcester, MA

Publish date: March 10, 2023

A final rule requires that mammography facilities notify patients about the density of their breasts.

News

Phase 3 results: Ponatinib bests imatinib for Ph+ALL

Author:: Sharon Worcester, MA

Publish date: March 9, 2023

First prospective study of third-generation TKI ponatinib showed its comparative benefit for the most common subtype of adult ALL.

News

Popular book by USC oncologist pulled because of plagiarism

Author:: Sharon Worcester, MA

Publish date: March 8, 2023

The Los Angeles Times reported earlier this week that it identified at least 95 instances of plagiarism by Dr. David B. Agus.